About Bharat Parenterals Ltd
Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India.
Founded
1992
CEO
Bharat Kumar R Desai
Employees
393
HQ
Vadodara, Gujarat
Finished Products
1Sales
₹581.00Cr2Export Incentive
₹3.26Cr3Sale of Trading Goods
₹1.13Cr4Others
₹0.81Cr5Scrap Sales
₹0.67Cr6Product Development charges
₹0.21Cr7Packing charges
₹0.17Cr1–7 of 9
Raw Materials
1Raw Material Consumed
₹351.50Cr2Purchase of Traded goods
₹1.54CrAbout Bharat Parenterals Ltd
Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India.
Founded:1992
CEO:Bharat Kumar R Desai
Employees:393
HQ:Vadodara, Gujarat
Finished Products
1Sales
₹581.00Cr2Export Incentive
₹3.26Cr3Sale of Trading Goods
₹1.13Cr4Others
₹0.81Cr5Scrap Sales
₹0.67Cr6Product Development charges
₹0.21Cr7Packing charges
₹0.17Cr1–7 of 9
Raw Materials
1Raw Material Consumed
₹351.50Cr2Purchase of Traded goods
₹1.54CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,649
52W Low
₹1,126
Volume524
Avg VolumeN/A
Beta0.78
Dividend Yield0.06%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-35.64x
Valuation
P/B Ratio
3.32x
Valuation
EPS
₹-43.52
Valuation
Dividend Yield
0.06%
Valuation
ROE
-2.54%
Profitability
ROCE
-1.83%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing of Pharmaceucals FormRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
32.7%
International
67.3%
Outside India67.3%
Within India32.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.45x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
16.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.